PGEN:NASDAQ
Precigen Inc
US$ 7.36
arrow_downward
-1.67%(-0.12) Siku 1
US$ 7.30
arrow_downward
-0.75% (-0.055)bedtimeBaada ya saa
Imefungwa: 14 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya PGEN...
Fungua
US$ 7.48
Juu
US$ 7.70
Chini
US$ 7.33
Mtaji wa soko
2.63B
Wastani wa kiasi cha mauzo
4.68M
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 8.98
Chini kwa wiki 52
US$ 3.04
EPS
-US$ 1.10
Beta
0.92
Hisa za wawekezaji
358.04M
Idadi ya wafanyakazi
160
Fungua
US$ 7.48
Juu
US$ 7.70
Chini
US$ 7.33
Mtaji wa soko
2.63B
Wastani wa kiasi cha mauzo
4.68M
Kiasi cha mauzo ya hisa
0.00
Juu kwa wiki 52
US$ 8.98
Chini kwa wiki 52
US$ 3.04
EPS
-US$ 1.10
Beta
0.92
Hisa za wawekezaji
358.04M
Idadi ya wafanyakazi
160
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Yahoo Finance
·
siku 2 zilizopita
Precigen (PGEN): Commercial Launch Success Validates Early Capital Raise Thesis
Wasifu
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
Kuhusu Precigen Inc
Afisa Mkuu Mtendaji (CEO)Helen Sabzevari
Wafanyakazi160
Lilianzishwa21 Mei 1998
Makao makuu-
Sekta-
Tovutiprecigen.com